text: Vasdev has introduced new radiochemical methods and radiopharmaceuticals for imaging the living human brain. The Vasdev Lab is exploring new ways to image neuroinflammation and tau protein. He is the co-inventor of the method patent for the first and only FDA-approved tau-PET radiopharmaceutical Tauvid that has been employed worldwide to image patients with Alzheimer's disease (AD) and related dementias, as well as patients with symptomatic traumatic brain injuries, including professional athletes and military veterans. The Vasdev Lab is partnering with Concussion Legacy Foundation Canada and the Canadian Military to work on the Project Enlist to study whether some military training exercises could be negatively impacting long-term brain health. “We are getting very close to advancing new radio tracers in humans to image the tau that is more prevalent in C.T.E.”.